Doxorubicin, sold under the brand name Adriamycin among others, is a chemotherapy medication used to treat cancer.
| FactSnippet No. 736,422 |
Doxorubicin, sold under the brand name Adriamycin among others, is a chemotherapy medication used to treat cancer.
| FactSnippet No. 736,422 |
Doxorubicin is in the anthracycline and antitumor antibiotic family of medications.
| FactSnippet No. 736,423 |
Doxorubicin hydrochloride is indicated to treat breast cancer in combination with cyclophosphamide.
| FactSnippet No. 736,425 |
Doxorubicin is commonly used to treat some leukemias and Hodgkin's lymphoma, as well as cancers of the bladder, breast, stomach, lung, ovaries, thyroid, soft tissue sarcoma, multiple myeloma, and others.
| FactSnippet No. 736,426 |
Doxorubicin-induced cardiomyopathy typically results in dilated cardiomyopathy, with all four cardiac chambers being enlarged.
| FactSnippet No. 736,427 |
Doxorubicin is a 14-hydroxylated version of daunorubicin, the immediate precursor of DXR in its biosynthetic pathway.
| FactSnippet No. 736,428 |
Doxorubicin's group cloned many of the genes required for DXR production, although not all of them have been fully characterized.
| FactSnippet No. 736,429 |
Doxorubicin showed better activity than daunorubicin against mouse tumors, and especially solid tumors.
| FactSnippet No. 736,430 |
Doxorubicin is available in liposome-encapsulated forms as Doxil, Myocet, and Caelyx, which are given by intravenous injection.
| FactSnippet No. 736,431 |
Doxorubicin fluorescence is quenched by binding to DNA, and shielded by micelle encapsulation.
| FactSnippet No. 736,432 |